Related Experiment Videos
The partial retro-inverso modification: a road traveled together
1Harvard Medical School, Laboratory for Translational Research, One Kendall Square, Building 600, 3rd Floor, Cambridge, MA 02139, USA. michael_chorev@hms.harvard.edu
Biopolymers
|February 25, 2005
Summary
Dr. Murray Goodman pioneered retro-inverso transformations, modifying peptide bonds to create novel bioactive molecules. His work revived this field, leading to advancements in immunology and drug delivery.
Area of Science:
- Medicinal Chemistry
- Peptide Chemistry
- Organic Synthesis
Background:
- Exploration of reversed peptide bonds as surrogates for amide bond functional studies.
- Initial investigations into aspartame, a dipeptide sweetener, sparked broader research into retro-inverso modifications.
Discussion:
- Development of novel concepts like partially modified and end-group modified retro-inverso transformations.
- Characterization of unique building blocks, including gem-diaminoalkyl and C2-substituted malonyl residues.
- Study of biological activities of retro-inverso isomers of bioactive peptides.
Key Insights:
- The retro-inverso modification offers significant potential for creating novel chemical entities.
- This modification has led to new synthetic methodologies and a deeper understanding of conformational and topological properties.
- The field experienced a revival in the early 1980s, attracting extensive research.
Outlook:
- Applications in immunology, including synthetic vaccines, immunomodulators, and diagnostic tools.
- Integration into drug delivery systems for targeted and non-targeted cell permeation vectors.
- Continued exploration of retro-inverso chemistry's potential in various scientific disciplines.